JP2016501260A - マルトトリオースで被覆された第四世代ポリプロピレンイミンデンドリマーPPI−G4−DS−Mal−IIIの使用 - Google Patents
マルトトリオースで被覆された第四世代ポリプロピレンイミンデンドリマーPPI−G4−DS−Mal−IIIの使用 Download PDFInfo
- Publication number
- JP2016501260A JP2016501260A JP2015546418A JP2015546418A JP2016501260A JP 2016501260 A JP2016501260 A JP 2016501260A JP 2015546418 A JP2015546418 A JP 2015546418A JP 2015546418 A JP2015546418 A JP 2015546418A JP 2016501260 A JP2016501260 A JP 2016501260A
- Authority
- JP
- Japan
- Prior art keywords
- ppi
- mal
- dendrimer
- iii
- cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/132—Amines having two or more amino groups, e.g. spermidine, putrescine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PLP.401934 | 2012-12-06 | ||
| PL401934A PL234887B1 (pl) | 2012-12-06 | 2012-12-06 | Dendrymer polipropylenoiminowy czwartej generacji opłaszczony maltotriozą PPI-G4-DS-Mal-III do zastosowania w leczeniu przewlekłej białaczki limfocytowej |
| PCT/PL2013/000154 WO2014088434A1 (en) | 2012-12-06 | 2013-12-03 | Application of maltotriose-coated 4th generation polypropyleneimine dendrimer ppi-g4-ds-mal-iii |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2016501260A true JP2016501260A (ja) | 2016-01-18 |
| JP2016501260A5 JP2016501260A5 (cg-RX-API-DMAC10.html) | 2017-01-19 |
Family
ID=49955471
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015546418A Pending JP2016501260A (ja) | 2012-12-06 | 2013-12-03 | マルトトリオースで被覆された第四世代ポリプロピレンイミンデンドリマーPPI−G4−DS−Mal−IIIの使用 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20150320692A1 (cg-RX-API-DMAC10.html) |
| EP (1) | EP2928478A1 (cg-RX-API-DMAC10.html) |
| JP (1) | JP2016501260A (cg-RX-API-DMAC10.html) |
| KR (1) | KR20150099539A (cg-RX-API-DMAC10.html) |
| AU (1) | AU2013356792A1 (cg-RX-API-DMAC10.html) |
| CA (1) | CA2896673A1 (cg-RX-API-DMAC10.html) |
| IL (1) | IL239143A0 (cg-RX-API-DMAC10.html) |
| PL (1) | PL234887B1 (cg-RX-API-DMAC10.html) |
| WO (1) | WO2014088434A1 (cg-RX-API-DMAC10.html) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2016501261A (ja) * | 2012-12-06 | 2016-01-18 | ウニヴェルシテット・ウズキUniwersytet Lodzki | マルトトリオースで被覆された第四世代ポリプロピレンイミンデンドリマーPPI−G4−OS−Mal−IIIの使用 |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2016501261A (ja) * | 2012-12-06 | 2016-01-18 | ウニヴェルシテット・ウズキUniwersytet Lodzki | マルトトリオースで被覆された第四世代ポリプロピレンイミンデンドリマーPPI−G4−OS−Mal−IIIの使用 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20090208580A1 (en) * | 2005-09-19 | 2009-08-20 | Regents Of The University Of Michigan | Functionalized dendrimer-encapsulated and dendrimer-stabilized nanoparticles |
| US20110177602A1 (en) * | 2007-06-27 | 2011-07-21 | Endress + Hauser Conducts Gesellschaft furMess-und Regeltechnik mbH +Co. KG | Composite Structure |
-
2012
- 2012-12-06 PL PL401934A patent/PL234887B1/pl unknown
-
2013
- 2013-12-03 AU AU2013356792A patent/AU2013356792A1/en not_active Abandoned
- 2013-12-03 KR KR1020157018092A patent/KR20150099539A/ko not_active Withdrawn
- 2013-12-03 WO PCT/PL2013/000154 patent/WO2014088434A1/en not_active Ceased
- 2013-12-03 US US14/650,458 patent/US20150320692A1/en not_active Abandoned
- 2013-12-03 EP EP13821003.4A patent/EP2928478A1/en not_active Withdrawn
- 2013-12-03 CA CA2896673A patent/CA2896673A1/en not_active Abandoned
- 2013-12-03 JP JP2015546418A patent/JP2016501260A/ja active Pending
-
2015
- 2015-06-02 IL IL239143A patent/IL239143A0/en unknown
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2016501261A (ja) * | 2012-12-06 | 2016-01-18 | ウニヴェルシテット・ウズキUniwersytet Lodzki | マルトトリオースで被覆された第四世代ポリプロピレンイミンデンドリマーPPI−G4−OS−Mal−IIIの使用 |
Non-Patent Citations (4)
| Title |
|---|
| A. JANASZEWSKA, NEW JOURNAL OF CHEMISTRY, vol. V36 N2, JPN5016000505, 1 January 2012 (2012-01-01), pages 428 - 437, ISSN: 0003609146 * |
| BARBARA ZIEMBA, BIOPOLYMERS, vol. V97 N8, JPN5016000507, 17 August 2012 (2012-08-17), pages 642 - 648, ISSN: 0003609147 * |
| BARBARA ZIEMBA: "INFLUENCE OF FOURTH GENERATION POLY (PROPYLENEIMINE) DENDRIMERS ON BLOOD CELLS", JOURNAL OF BIOMEDICAL METERIALS RESEARCH PART A, vol. V100A N11, JPN5016000506, 24 November 2012 (2012-11-24), pages 2870 - 2880, ISSN: 0003753522 * |
| FRANIAK-PIETRYGA IDA, BLOOD, vol. V120 N21, JPN5016000504, 16 November 2012 (2012-11-16), pages 4601, ISSN: 0003609145 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2016501261A (ja) * | 2012-12-06 | 2016-01-18 | ウニヴェルシテット・ウズキUniwersytet Lodzki | マルトトリオースで被覆された第四世代ポリプロピレンイミンデンドリマーPPI−G4−OS−Mal−IIIの使用 |
Also Published As
| Publication number | Publication date |
|---|---|
| PL234887B1 (pl) | 2020-04-30 |
| EP2928478A1 (en) | 2015-10-14 |
| US20150320692A1 (en) | 2015-11-12 |
| KR20150099539A (ko) | 2015-08-31 |
| IL239143A0 (en) | 2015-07-30 |
| AU2013356792A1 (en) | 2015-07-23 |
| CA2896673A1 (en) | 2014-06-12 |
| PL401934A1 (pl) | 2014-06-09 |
| WO2014088434A1 (en) | 2014-06-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Zhao et al. | Sonodynamic therapy of NRP2 monoclonal antibody‐guided MOFs@ COF targeted disruption of mitochondrial and endoplasmic reticulum homeostasis to induce autophagy‐dependent ferroptosis | |
| Nooshabadi et al. | Impact of atorvastatin loaded exosome as an anti-glioblastoma carrier to induce apoptosis of U87 cancer cells in 3D culture model | |
| Zeller et al. | A novel phosphocholine‐mimetic inhibits a pro‐inflammatory conformational change in C‐reactive protein | |
| US9861659B2 (en) | Pharmaceutical composition for improving health, cure abnormalities and degenerative disease, achieve anti-aging effect of therapy and therapeutic effect on mammals and method thereof | |
| He et al. | Inhibition of Aurora kinases induces apoptosis and autophagy via AURKB/p70S6K/RPL15 axis in human leukemia cells | |
| Gravelle et al. | Cell growth in aggregates determines gene expression, proliferation, survival, chemoresistance, and sensitivity to immune effectors in follicular lymphoma | |
| CN111787945A (zh) | 作为癌症免疫治疗的检查点阻断剂的工程化纳米囊泡 | |
| JP2023055865A (ja) | ルテリアル、並びにその分離および培養方法 | |
| Mameri et al. | Oxidative stress as an underlying mechanism of anticancer drugs cytotoxicity on human red blood cells' membrane | |
| Pidala et al. | Ixazomib for treatment of refractory chronic graft-versus-host disease: a chronic GVHD consortium phase II trial | |
| Albuz et al. | Effects of B2O3 (boron trioxide) on colon cancer cells: our first-step experience and in vitro results | |
| Ünsal et al. | The apoptotic effect of garlic (Allium sativum) derived SEVs on different types of cancer cell lines in vitro | |
| WO2020031136A1 (en) | Theranostics-like protein sanps conjugated to integrin and pmsa targeting peptides and therapy of prostate cancer | |
| US9877985B2 (en) | Application of maltotriose-coated 4th generation polypropyleneimine dendrimer PPI-G4-OS-MAL-III | |
| US20150320692A1 (en) | Application of maltotriose-coated 4th generation polypropyleneimine dendrimer ppi-g4-ds-mal-iii | |
| US10022395B2 (en) | Application of maltotriose-coated 4th generation poly(propyleneimine) dendrimer PPI-G4-OS-Mal-III | |
| EP3928792A1 (en) | Peripheral blood biomarker for evaluating anti-tumor immune effect of radiation therapy | |
| CN116785256A (zh) | 一种可诱导细胞免疫性死亡的纳米颗粒材料及其制备方法和应用 | |
| Zhang et al. | Caerulomycin A disrupts glucose metabolism and triggers ER stress-induced apoptosis in triple-negative breast cancer cells | |
| Donmez et al. | Investigation of the Effects of Three Different Generations of Fluoroquinolone Derivatives on Erythrocyte Fragility and Hematological Parameters in Rats | |
| JP2004534001A (ja) | 細胞に化学化合物を標的化する方法およびそれに使用する製薬学的組成物 | |
| Huang et al. | Preparation and biocompatibility evaluation of PEG-PLL/RGD-PEG-DSPE/Phospholipid/CaP nanoparticles | |
| RU2810558C1 (ru) | Способ подбора лекарственных средств для реализации фармакологической индукции митохондриальной дисфункции в макрофагах для противоопухолевой терапии | |
| WO2017163124A2 (en) | Medical use of poly(propylene imine) glycodendrimers | |
| Widodo et al. | Immunohistochemical differential expression of p16 proteins in follicular type and plexiform type ameloblastoma |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RD04 | Notification of resignation of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7424 Effective date: 20160218 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20161202 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20161202 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20170801 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20171031 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20171227 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20180201 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20180313 |